ALK Positive is a large worldwide community of lung cancer patients and their families. We are dedicated to advancing research and awareness for ALK-positive lung cancer. Our goal is for patients with ALK-positive lung cancer to obtain more durable responses to treatments, live longer, and to render ALK-positive lung cancer a chronic, even curable, disease.
EGFR Resisters is comprised of over 825 members from 26 countries. They work to increase the size of our EGFR Resisters community with the assistance of advocacy groups and medical professionals. Their aim is to use the strength of our collaboration to drive important research questions and fund novel research and clinical trials.
GO2 Foundation for Lung Cancer transforms survivorship as the world’s leading organization dedicated to saving, extending, and improving the lives of those vulnerable, at risk, and diagnosed with lung cancer. We work to change the reality of living with lung cancer by ending stigma, increasing public and private research funding, and ensuring access to care.
LUNGevity Foundation is firmly committed to making an immediate impact on increasing quality of life and survivorship of people with lung cancer by accelerating research into early detection and more effective treatments, as well as providing community, support, and education for all those affected by the disease. Our vision is a world where no one dies of lung cancer.
As the state’s leading non-profit organization supporting lung cancer research and education, Lung Cancer Initiative of North Carolina specializes in connecting patients, survivors and loved ones with the medical and research community.
The Lung Cancer Research Foundation (LCRF) is the pre-eminent nonprofit organization focused on funding innovative, high-reward research with the potential to extend survival and improve quality of life for people with lung cancer. LCRF’s mission is to improve lung cancer outcomes by funding research for the prevention, diagnosis, treatment and cure of lung cancer. To date, LCRF has funded 362 research grants, totaling nearly $33 million, the highest amount provided by a nonprofit organization dedicated to funding lung cancer research. The Lung Cancer Research Foundation also hosts community events across the country through the Free to Breathe Events Program.
The ROS1ders is a global group of patients and caregivers dealing with ROS1+ cancer. They strive to better outcomes for all ROS1+ cancers by supporting patients and caregivers, increasing awareness and education, accelerating research, and improving access to effective diagnosis and treatment.
